The myosin family of molecular motors plays crucial roles in contraction, diverse forms of cell movement, and changes in cell shape. Myosin II is a non-processive motor that drives cytokinesis and muscle contraction, and myosin V and VI are processive motors that drive vesicular movements in neurons and other cells. The molecular basis of myosin function has reached a detailed level of analysis, due to the advent of in vitro motility assays, total internal reflection fluorescence microscopy for measuring movement of single molecules, and the establishment of laser trap assays that allow the direct measurement of force and displacement produced by a single myosin molecule pulling on a single actin filament.
The specific aims of this proposal are to continue to develop these assays, and to use them and other approaches to examine the mechanical and biochemical parameters of native and mutated forms of both myosin V and myosin VI. We will also initiate studies on other members of the myosin family. Specific goals involving myosin V include preparation and characterization of a two-headed construct of myosin V joined by a totally flexible hinge, to test the role of the proximal """"""""hip"""""""" region in processive movement. We will visualize individual fluorescent nucleotides as they come on and off myosin V during the stepping process to test models of chemomechanical coupling. These studies will be complemented with determination of the effects of both backward and forward external loads on the behavior of myosin V stepping. Similar studies will be carried out with myosin VI and other myosin family members, including preparation of altered forms of the motors to examine the roles of various domains. A primary goal for this grant period is to determine the molecular basis of movement of myosin VI, which is a non-classical myosin that moves by an unknown mechanism, but may involve the melting out of some part of the protein in a nucleotide dependent manner. We will use multiple approaches to reveal regions that become exposed during its chemomechanical cycle.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM033289-22
Application #
6876658
Study Section
Biophysical Chemistry Study Section (BBCB)
Program Officer
Rodewald, Richard D
Project Start
1984-04-01
Project End
2008-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
22
Fiscal Year
2005
Total Cost
$494,174
Indirect Cost
Name
Stanford University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Liu, Chao; Kawana, Masataka; Song, Dan et al. (2018) Controlling load-dependent kinetics of ?-cardiac myosin at the single-molecule level. Nat Struct Mol Biol 25:505-514
Trivedi, Darshan V; Adhikari, Arjun S; Sarkar, Saswata S et al. (2018) Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light. Biophys Rev 10:27-48
Kawana, Masataka; Sarkar, Saswata S; Sutton, Shirley et al. (2017) Biophysical properties of human ?-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy. Sci Adv 3:e1601959
Gangadharan, Binnu; Sunitha, Margaret S; Mukherjee, Souhrid et al. (2017) Molecular mechanisms and structural features of cardiomyopathy-causing troponin T mutants in the tropomyosin overlap region. Proc Natl Acad Sci U S A 114:11115-11120
Sung, J; Mortensen, K I; Spudich, J A et al. (2017) How to Measure Load-Dependent Kinetics of Individual Motor Molecules Without a Force-Clamp. Methods Enzymol 582:1-29
Nag, Suman; Trivedi, Darshan V; Sarkar, Saswata S et al. (2017) The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations. Nat Struct Mol Biol 24:525-533
Spudich, James A; Aksel, Tural; Bartholomew, Sadie R et al. (2016) Effects of hypertrophic and dilated cardiomyopathy mutations on power output by human ?-cardiac myosin. J Exp Biol 219:161-7
Green, Eric M; Wakimoto, Hiroko; Anderson, Robert L et al. (2016) A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science 351:617-21
Spudich, James A (2015) The myosin mesa and a possible unifying hypothesis for the molecular basis of human hypertrophic cardiomyopathy. Biochem Soc Trans 43:64-72
Mortensen, Kim I; Sung, Jongmin; Flyvbjerg, Henrik et al. (2015) Optimized measurements of separations and angles between intra-molecular fluorescent markers. Nat Commun 6:8621

Showing the most recent 10 out of 101 publications